Related Experiment Video
Updated: Aug 13, 2025

Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
Published on: July 31, 2021
COVID-19 Vaccines during Pregnancy and Breastfeeding: A Systematic Review
Blanca Novillo1, Alicia Martínez-Varea1
1Department of Obstetrics and Gynaecology, La Fe University and Polytechnic Hospital, Avenida Fernando Abril Martorell 106, 46026 Valencia, Spain.
Insights
COVID-19 vaccines are recommended for pregnant and breastfeeding individuals, offering protection against severe illness and providing passive immunity to newborns. Vaccination is safe, with minor side effects like injection site pain.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Pregnant and breastfeeding women lacked clear COVID-19 vaccine guidance initially.
- Exclusion from early clinical trials created uncertainty.
- This review addresses COVID-19 vaccination data for these populations.
Purpose of the Study:
- To update knowledge on COVID-19 vaccines in pregnancy and breastfeeding.
- To synthesize evidence on safety and efficacy.
- To inform clinical recommendations.
Main Methods:
- Systematic literature review using Medline/PubMed.
- Adherence to PRISMA guidelines.
- Inclusion of studies on COVID-19 vaccination in pregnant and breastfeeding women.
Main Results:
- 33 studies analyzed; common adverse effect is injection site pain.
- More frequent side effects after the second dose, slightly more with Moderna.
- Vaccination reduces severe COVID-19 risk in pregnant women.
- Induces maternal active and neonatal passive immunity; breast milk provides antibody and cellular protection.
- Neonatal benefits include robust Immunoglobulin G response; infection yields Immunoglobulin A response.
Conclusions:
- COVID-19 vaccines are strongly recommended for pregnant and breastfeeding individuals.
- Vaccination protects both mothers and newborns.
- Evidence supports vaccine safety and immunogenicity in these groups.
Abstract:
Background: Pregnant and breastfeeding women received unclear recommendations regarding COVID-19 vaccination at the beginning of the pandemic, as they were not included in the initial clinical trials. This systematic review aims to provide an update regarding COVID-19 vaccines during pregnancy and breastfeeding. Methods: The systematic review was carried out through a literature search in Medline/Pubmed. Studies were selected if they included information regarding COVID-19 vaccination during pregnancy and breastfeeding. The PRISMA guidelines for systematic reviews were followed. Results: A total of 33 studies were included. The main adverse effect is pain at the injection site, as in the general population. Adverse effects are more frequent after the second dose, being slightly more frequent after the Moderna vaccine. COVID-19 vaccination reduces the risk of severe COVID-19 in pregnant women. Additionally, COVID-19 vaccination induces artificial active immunogenicity in the mother and natural passive immunogenicity in the child. Breastmilk straddles both immediate antibody-mediated and long-lived cellular-mediated immune protection. Regarding neonatal benefits, vaccination is associated with a larger and more stable Immunoglobulin G response, while COVID-19 Infection is associated with a rapid and long-lasting Immunoglobulin A response. Conclusions: COVID-19 vaccines are not only suggested but strongly recommended for pregnant and breastfeeding populations to protect mothers and newborns.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
08:12Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
Related Concept Videos
Teratogenicity
Vaccinations
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...